Sensus Healthcare Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $2.81
- Today's High:
- $2.93
- Open Price:
- $2.81
- 52W Low:
- $2.29
- 52W High:
- $15.17
- Prev. Close:
- $2.85
- Volume:
- 23420
Company Statistics
- Market Cap.:
- $46.72 million
- Book Value:
- 2.806
- Revenue TTM:
- $30.06 million
- Operating Margin TTM:
- 7.55%
- Gross Profit TTM:
- $29.63 million
- Profit Margin:
- 7.93%
- Return on Assets TTM:
- 2.62%
- Return on Equity TTM:
- 5.24%
Company Profile
Sensus Healthcare Inc had its IPO on 2016-06-03 under the ticker symbol SRTS.
The company operates in the Healthcare sector and Medical Devices industry. Sensus Healthcare Inc has a staff strength of 42 employees.
Stock update
Shares of Sensus Healthcare Inc opened at $2.81 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $2.81 - $2.93, and closed at $2.85.
This is a 0% increase from the previous day's closing price.
A total volume of 23,420 shares were traded at the close of the day’s session.
In the last one week, shares of Sensus Healthcare Inc have slipped by -8.65%.
Sensus Healthcare Inc's Key Ratios
Sensus Healthcare Inc has a market cap of $46.72 million, indicating a price to book ratio of 2.2896 and a price to sales ratio of 2.3244.
In the last 12-months Sensus Healthcare Inc’s revenue was $30.06 million with a gross profit of $29.63 million and an EBITDA of $2.57 million. The EBITDA ratio measures Sensus Healthcare Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Sensus Healthcare Inc’s operating margin was 7.55% while its return on assets stood at 2.62% with a return of equity of 5.24%.
In Q2, Sensus Healthcare Inc’s quarterly earnings growth was a negative -45.8% while revenue growth was a negative 62.5%.
Sensus Healthcare Inc’s PE and PEG Ratio
- Forward PE
- 5.4585
- Trailing PE
- 20.3571
- PEG
- 0
Its diluted EPS in the last 12-months stands at $0.14 per share while it has a forward price to earnings multiple of 5.4585 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Sensus Healthcare Inc’s profitability.
Sensus Healthcare Inc stock is trading at a EV to sales ratio of 1.6058 and a EV to EBITDA ratio of 2.4375. Its price to sales ratio in the trailing 12-months stood at 2.3244.
Sensus Healthcare Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $52.02 million
- Total Liabilities
- $5.19 million
- Operating Cash Flow
- $-29000.00
- Capital Expenditure
- $29000
- Dividend Payout Ratio
- 0%
Sensus Healthcare Inc ended 2025 with $52.02 million in total assets and $0 in total liabilities. Its intangible assets were valued at $52.02 million while shareholder equity stood at $46.01 million.
Sensus Healthcare Inc ended 2025 with $116000.00 in deferred long-term liabilities, $5.19 million in other current liabilities, 169000.00 in common stock, $4.03 million in retained earnings and $0 in goodwill. Its cash balance stood at $20.05 million and cash and short-term investments were $20.05 million. The company’s total short-term debt was $181,000 while long-term debt stood at $0.
Sensus Healthcare Inc’s total current assets stands at $47.39 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $9.15 million compared to accounts payable of $3.94 million and inventory worth $10.13 million.
In 2025, Sensus Healthcare Inc's operating cash flow was $-29000.00 while its capital expenditure stood at $29000.
Comparatively, Sensus Healthcare Inc paid $0 in dividends in 2025.
Other key metrics
- Current Trading Price
- $2.85
- 52-Week High
- $15.17
- 52-Week Low
- $2.29
- Analyst Target Price
- $8.2
Sensus Healthcare Inc stock is currently trading at $2.85 per share. It touched a 52-week high of $15.17 and a 52-week low of $15.17. Analysts tracking the stock have a 12-month average target price of $8.2.
Its 50-day moving average was $3.15 and 200-day moving average was $4.99 The short ratio stood at 0.66 indicating a short percent outstanding of 0%.
Around 2123.3% of the company’s stock are held by insiders while 3101.1% are held by institutions.
Frequently Asked Questions About Sensus Healthcare Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and TransDermal Infusion system. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body, as well as distributes laser devices. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.